Top Story

ATMOSPHERE: Aliskiren fails to benefit patients with HF, diabetes vs. enalapril

May 26, 2016

In patients with diabetes and HF, the direct renin inhibitor aliskiren did not significantly improve outcomes compared with the ACE inhibitor enalapril, according to new data from the ATMOSPHERE trial.

In the overall results, presented in April, aliskiren (Tekturna, Novartis) alone or combined with enalapril did not improve CV mortality or hospitalization for HF compared with enalapril alone.

Meeting News Coverage

Insulin resistance a culprit for non-alcoholic fatty liver disease

May 21, 2016
NEW ORLEANS — The prevalence of nonalcoholic fatty liver disease is high in patients with diabetes, and insulin resistance is a common cause, according to a…
Meeting News Coverage

Despite guideline changes, statin use unchanged or lower in patients with diabetes

May 21, 2016
NEW ORLEANS — The rate of statin use in adults with diabetes has remained steady or declined since 2014, according to findings presented at the National Lipid…
Trial Scorecards

Trial Scorecard: STAMPEDE

Cardiology Today, May 2016
Researchers compared outcomes of intensive medical therapy, Roux-en-Y gastric bypass surgery or sleeve gastrectomy in patients with mild to moderate obesity and type 2…
In the Journals

Air pollution increases CVD risk in women with diabetes

December 1, 2015
Women with diabetes exposed to long-term traffic pollution have a 44% increased risk for cardiovascular disease and a 66% increased risk for stroke…

In the Journals

Stroke risk higher among adults with congenital heart disease

November 24, 2015
Adults born with a heart defect are at substantially higher risk for stroke compared with the general population, according to results published in…


Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

November 20, 2015 Expires: 11/19/2016
In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes mellitus (T2DM). While…

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.


The Patient with Coronary Artery Disease and an Acute Ischemic Stroke

November 15, 2015 Expires: 11/15/2016
Patients with hypertension, coronary artery disease, systemic atherosclerosis and heart failure are at increased risk for acute ischemic stroke. The…

No commercial support for this activity.

Meeting News CoverageVideo

VIDEO: Extended-release aspirin provides stable antiplatelet effect

November 14, 2015
ORLANDO, Fla. — In this video, Paul A. Gurbel, MD, director of interventional cardiology and cardiovascular research at Inova Heart and…

In the Journals

Public transportation linked to lower risk of diabetes, hypertension, body fat

November 12, 2015
ORLANDO, Fla. — In Japan, individuals who took public transportation were 44% less likely to be overweight, 27% less likely to have elevated BP…

Meeting News CoveragePerspective

EMPA-REG Outcome: Empagliflozin reduces risk for HF endpoints

November 9, 2015
ORLANDO, Fla. — Empagliflozin, an SGLT2 inhibitor, is associated with decreased risk for HF hospitalization or CV death and other HF-related…

In the Journals

Moderate wine intake may reduce cardiometabolic risk in adults with diabetes

November 6, 2015
Moderate consumption of alcohol, especially red wine, in addition to a healthy diet may modestly reduce cardiometabolic risk among patients with…

Meeting News CoveragePerspective

MAJESTIC: DES to treat femoropopliteal lesions shows high patency, low TLR

November 2, 2015
LAS VEGAS — A drug-eluting stent was safe and had a high patency rate in patients with femoropopliteal artery lesions, regardless of whether a…

Meeting News Coverage

Heritability of PCOS provides clues for metabolic risk

October 28, 2015
BOSTON — Polycystic ovary syndrome is the most powerful predictor of type 2 diabetes in young women, but the disorder also offers clues for…

More Headlines »